Home/Filings/4/0001694665-23-000015
4//SEC Filing

GILL SIMBA 4

Accession 0001694665-23-000015

CIK 0001694665other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:38 PM ET

Size

7.7 KB

Accession

0001694665-23-000015

Insider Transaction Report

Form 4
Period: 2023-02-07
GILL SIMBA
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-07+1,125,0001,125,000 total
    Exercise: $0.97Exp: 2033-02-07Common Stock (1,125,000 underlying)
  • Award

    Restricted Stock Units

    2023-02-07+375,000375,000 total
    Exercise: $0.00Common Stock (375,000 underlying)
Footnotes (2)
  • [F1]The options vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to the reporting person's continued service to the issuer on each such vesting date.
  • [F2]The Restricted Stock Units vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date.

Issuer

Evelo Biosciences, Inc.

CIK 0001694665

Entity typeother

Related Parties

1
  • filerCIK 0001180763

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:38 PM ET
Size
7.7 KB